Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL
Clinical trial NCT05287984 · UNKNOWN
Trial details
- NCT number
- NCT05287984
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2024-06-28
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.